BMS-986165 is one such novel oral agent that inhibits tyrosine kinase 2 and is a promising future therapeutic agent for patients with plaque psoriasis.
BMS-986165 is one such novel oral agent that inhibits tyrosine kinase 2 and is a promising future therapeutic agent for patients with plaque psoriasis.
BMS-986165 is one such novel...